Episode 189 Ovarian Cancer with Michele Collins
After her own struggles with ovarian cancer, Michele Collins became an advocate to raise awareness for this disease. Although considered rare, over 22, 000 women are diagnosed every year, and more than half of them die. Through connections, awareness and advocacy, Michele is aiming to teach women the signs and symptoms of this disease so they can obtain and early diagnosis and hopefully reduce the mortality rate. Through www.sharecancersuppodrt.org women can find support, information and the latest research.
Michele is a mom of two teens, school psychologist, kitten fosterer & advocate for ovarian cancer awareness & research. She was diagnosed at age 39 with Stage 2B High Grade Serous Ovarian Cancer. She did not have any risk factors or genetic mutations. After a radical hysterectomy & six cycles of chemo at MSK, she’s been in remission for the last four years. Michele volunteers with SHARE’s Pink and Teal program, giving talks about ovarian cancer and advocacy at corporate workplaces.
Topics covered in this episode:
- How did you get involved with Ovarian cancer?
- How did you feel after your diagnosis?
- Did you find you had a lot of support?
- What is ovarian cancer?
- What are the symptoms of ovarian cancer?
- How is ovarian cancer diagnosed?
- Who is at risk for ovarian cancer?
- Do we know what causes ovarian cancer?
- Is ovarian cancer linked to genetics?
- Is there a link between ovarian cancer and other cancers like breast cancer?
- Does hormone replacement therapy increase the risk for ovarian cancer?
- Does the use of Talcum powder increase the risk for ovarian cancer?
- What type of doctor is best trained to treat ovarian cancer?
- Can endometriosis cause ovarian cancer?
- What are ovarian cysts? Can they indicate ovarian cancer?
- Do fertility drugs increase your risk of developing ovarian cancer?
- What is the treatment for ovarian cancer?
- What outcomes can a patient expect after treatment?
- Are there any medications that can treat ovarian cancer?
- If we were to look into the future, what changes can we see happening for ovarian cancer?